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Abstract
Background: Individuals with advanced hip osteoarthritis (OA) exhibit generalized muscle weakness of the affected
limb and so clinical practice guidelines recommend strength training for the management of hip OA. However, the
extent and pattern of muscle weakness, including any between-limb asymmetries, in early stages of the disease are
unclear. This study compared hip and knee muscle strength and volumes between individuals with mild-to-moderate
symptomatic and radiographic hip OA and a healthy control group.
Methods: Nineteen individuals with mild-to-moderate symptomatic and radiographic hip OA (n = 12 unilateral; n = 7
bilateral) and 23 age-matched, healthy controls without radiographic hip OA or hip pain participated. Isometric
strength of the hip and knee flexors and extensors, and hip abductors and adductors were measured. Hip and thigh
muscle volumes were measured from lower limb magnetic resonance images. A full-factorial, two-way General Linear
Model was used to assess differences between groups and between limbs.
Results: Participants in the hip OA group demonstrated significantly lower knee flexor, knee extensor, hip flexor, hip
extensor and hip abductor strength compared to controls and had significantly lower volume of the adductor, hamstring
and quadriceps groups, and gluteus maximus and gluteus minimus muscles, but not tensor fasciae latae or gluteus
medius muscles. There were no between-limb strength differences or volume differences within either group.
Conclusions: Atrophic, bilateral hip and knee muscle weakness is a feature of individuals with mild-to-moderate hip OA.
Early interventions to target muscle weakness and prevent the development of strength asymmetries that are characteristic
of advanced hip OA appear warranted.
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Background
People with hip osteoarthritis (OA) often experience
joint pain, stiffness, reduced joint range of motion, and
muscle weakness [1–4]. These deficits can limit per-
formance of activities of daily living and diminish quality
of life [5]. Hip OA has no cure, and progression to more
advanced disease occurs in many patients. Conservative
non-pharmacological interventions focus primarily on al-
leviating pain and improving function [6–11]. Individuals
with advanced hip OA exhibit generalized muscle weak-
ness of the affected limb [12–19], which is underpinned
by a combination of muscle atrophy [16, 18, 20–22], re-
duced muscle density [14, 21, 22], and muscle inhibition
[22]. Clinical practice guidelines recommend land-based
therapeutic exercise for the management of hip OA [23],
most notably resistance training, which can reduce pain,
stiffness and self-reported disability, and improve strength,
physical function and joint range of motion [24, 25]. At
present however, there is limited understanding of the
extent and pattern of muscle weakness in earlier stages of
the disease. If muscle weakness were also found to be a
feature of mild-moderate hip OA, then interventions such
as resistance training that target muscle weakness and
prevent the development of strength asymmetries
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characteristic of advanced hip OA [26] may be warranted
in earlier stages of the disease.
Most investigations of muscle properties in hip OA
have included individuals in advanced stages of the
disease [14, 16, 18, 20–22]. Studies that included patients
across the early spectrum of disease severity [12, 27] re-
ported lower gluteal muscle volumes in individuals with
unilateral hip OA compared to their contralateral side and
a group of healthy controls. Deficits in hip abduction and
internal rotation strength of the affected leg compared to
healthy controls were also noted and suggest that muscle
weakness could also be a feature of earlier stages of the
disease than previously reported. It therefore remains un-
clear whether muscle weakness and atrophy that precede
advanced stages of the disease extend beyond the abductor
muscle group of the affected leg to other prime movers (i.e.
quadriceps, hamstrings, adductors) within the most affected
leg or the contralateral leg. Evidence of between-limb dif-
ferences in hip and knee muscle strength and/or muscle
volume have been reported in advanced hip OA [12, 22]
and following total hip replacement [21]. While Grimaldi et
al. [20, 28] reported an absence of asymmetry in the
volume of the gluteal, piriformis, and tensor fascia latae
muscles in mild hip OA, symmetry of other important hip
and knee muscles is yet to be assessed. An improved under-
standing of whether muscle weakness and atrophy in
mild-to-moderate hip OA is generalized or specific to
certain muscles or muscle groups in the lower extremity is
required to appropriately inform and optimise management
programs.
The purpose of this study was to compare hip and
knee muscle strength and volumes between individuals
with mild-to-moderate symptomatic and radiographic
hip OA and a healthy control group. Based on evidence
from studies which report muscle weakness and atrophy
in knee OA [29], it was hypothesized that individuals
with mild-moderate hip OA would similarly exhibit
muscle weakness and lower limb muscle atrophy,




Individuals aged 45 to 80 years with symptomatic unilateral
or bilateral hip osteoarthritis were recruited from local
hospital orthopaedic waiting lists to participate in this
case-control study. Healthy controls were recruited through
advertising and word-of-mouth. All participants were
screened through radiographic examination (anterior-pos-
terior radiographs of the pelvis and hips) and self-reported
measures of pain and function (modified Harris Hip Score
(HHS) [30]). Unilateral and bilateral hip OA participants
were required to have hip pain and/or functional limitations
during activities of daily living (HHS ≤ 95; 0 = extreme hip
problems, 100 = no hip problems) and had a Kellgren-
Lawrence (KL) grade [31] for their affected hip(s) of 2 or 3
and/or joint space width (JSW) ≤ 3 mm). Unilateral hip OA
participants had KL scores of 0 or 1 for their contralateral
hip. Healthy controls were required to have no hip pain or
functional limitations during activities of daily living
(HHS > 95) and had KL grades ≤1 and JSW> 3 mm for
both hips. KL scores were determined by a single radiolo-
gist in a blinded manner from bilateral weight-bearing
radiographs performed in 15 degrees of femoral internal ro-
tation [32]. The same radiologist electronically measured
supero-medial, apical and supero-lateral hip JSW [33]. Ex-
clusion criteria for both groups included: (i) previous lower
limb or back fracture or surgery; (ii) history of trauma to
the hip joint or pelvis region; (iii) other forms of arthritis,
diabetes, cardiac or circulatory conditions; and (iv) use of
corticosteroid medication. All individuals were able to walk
without physical assistance or devices.
An a priori power analysis using hip abduction strength
data from Zacharias et al. [27] (hip OA= 0.15(0.09); con-
trols = 0.25(0.10)) estimated a minimum of 12 participants
were required in each group (significance level was set at
α= 0.05 and power at 0.80 (one tail)). Participants were
enrolled concurrently in another study [34]. This study
was approved by the institutional Human Research Ethics
Committee and written informed consent was obtained
from the participants prior to participating in the study.
Procedures
Participants initially attended a laboratory session to assess
bilateral isometric strength of the lower extremity muscles.
Anthropometric measures including height (m) and body
mass (kg) were also taken. Body mass index (BMI) was de-
termined as weight divided by the square of height (kg/m2).
Within 48 h of attending the strength testing session,
participants underwent bilateral magnetic resonance im-
aging (MRI) of their lower extremity in a private radiologic
clinic. This study conformed to the STROBE statement for
reporting case-control studies [35].
Maximal voluntary isometric hip and knee muscle
strength was measured using an isokinetic dynamometer
(Biodex System 4, Biodex Medical Systems, USA) using
a protocol adapted from Carty et al. [36]. Hip flexor,
extensor, adductor and abductor strength were assessed
while standing in 0° of hip flexion and adduction (neutral
position), with the knee constrained in 60° of flexion using
a post-surgical orthopaedic knee brace, and the ankle in 5°
of plantar flexion. Participants were allowed to apply a
light force against the dynamometer head for the purpose
of maintaining balance. Knee flexor and extensor strength
tests were performed while seated. Knee flexor strength
was assessed at 30° of knee flexion with the hip in 90° of
flexion and the ankle in 5° of plantar flexion. Knee exten-
sor strength was assessed at 60° of knee flexion with the
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hip in 70° of flexion and the ankle in 5° of plantar flexion.
The order of strength measurements was from hip to knee
randomized by limb. Participants performed a 5-s practice
trial at 75% of maximal effort for each exercise, followed
by a 60-s rest and a 5-s maximal contraction. Prior to each
maximal effort trial, participants were instructed to con-
tract as hard as they could for 5-s, with verbal encourage-
ment provided to help maximize effort. The instantaneous
peak isometric torque for each exercise was adjusted to
account for the torque due to the dynamometer attach-
ment and lower limb segments distal to the joint being
tested in accordance with the recommendations of Kellis
and Baltzopoulos [37], using body segment parameters es-
timated from Dempster [38]. Isometric strength at each
joint, in each direction, was defined as the peak torque
measured normalized to body mass (Nm/kg).
A 3.0 T MRI whole body scanner (Phillips Ingenia,
Phillips Medical, Netherlands), was used to image bilateral
lower limbs of all participants. Axial plane scans were per-
formed with participants positioned supine in the scanner
using body coil arrays placed superiorly on the limbs with
contiguous slices taken from approximately 2-cm superior
to the iliac crest to approximately 2-cm inferior to the
proximal tibio-fibula joint. Both lower limbs were scanned
simultaneously with T1 weighted 2-dimensional
gradient-recall acquisition in the steady state; slice
thickness 10-mm, inter-slice gap 1-mm, flip angle 900;
repetition time 677 msec, echo time 6.5 msec; field of view
280 × 500 × 219 mm; 352 × 499-pixel matrix; acquisition
time 1 min 29 s. Volumes of individual muscles (tensor fa-
sciae latae (TFL), gluteus maximus (GMax), gluteus med-
ius (GMed), gluteus minimus (GMin)) and muscle groups
(adductors (i.e. magnus, gracilis, brevis, and longus)
(Add), quadriceps (i.e. vastus medialis, vastus intermedius,
vastus lateralis, rectus femoris) (Quad), hamstrings (i.e.
semimembranosus, semitendinosus, biceps femoris)
(Hams)) were then calculated using Mimics software
(Materialise N.V., Belgium). The ilopsoas muscle was not
assessed as it was only partially visible in the MRI scans
obtained. Muscles were segmented on a slice-by-slice
basis by a single reader (AL) using the semi-automated
lasso tool (Fig. 1a). These data were then combined to
create the final 3-dimensional (3D) rendering. The
3D-volume object was wrapped using finest detail of
0.50 mm and a gap closing distance of 1.00 mm, followed
by a smoothing process with a factor of 1.0 and 4 itera-
tions. Finally, the muscle volumes were determined by
summing all pertinent pixels within the resultant binary
volume (Fig. 1b-c). Individual and group muscle volumes
were normalized to body mass (cm3/kg). Reliability of
muscle segmentation was assessed following the approach
described by Grimaldi et al. [20]. In brief this involved the
same investigator (AL) segmenting the same image slices
from all muscles for a single randomly selected participant
on 2 occasions, approximately 2 weeks apart. Intra-rater
reliability, as assessed using the intra-class correlation
coefficient (ICC) was high, with ICCs for all muscles in
excess of 0.985.
Statistical analysis
Shapiro-Wilk tests were used to examine data normality.
Demographic and clinical variables were compared
between groups using independent t-tests or Pearson’s
chi-square. A full-factorial, two-way General Linear
Model was used to assess the effect of a between subject
factor (Group) and a within subject factor (Leg) on
muscle strength and volume. A priori contrasts were
used to assess differences between limbs within each
group. Leg was defined as affected/contralateral for
participants with unilateral OA and most affected (on
the basis of symptoms)/less affected for participants with
bilateral OA. The test limb was randomly selected (left/
right) for control participants. Effect sizes for main
group effects were computed using Cohen’s d. Statistical
analyses were performed using SPSS version 17.0 for
Windows (SPSS Inc., Chicago, USA) with significance
level set at p < 0.05.
Results
There were no differences in age, height, or body mass
between the hip OA and control groups. On average,
participants in the hip OA group had a higher BMI than
participants in the control group (p < 0.01) (Table 1).
Lower limb strength
No group by leg interaction effects were detected for
any measure of lower-limb strength. A significant main
effect of group was detected for knee flexor, knee exten-
sor, hip flexor, hip extensor, hip abductor strength
(Table 2 and Fig. 2a), but not hip adductor strength. No
significant strength differences were detected between
legs within each group.
Hip and knee muscle volume
No group by leg interaction effects were detected for
any measure of hip or knee muscle volume. A significant
main effect of group was detected for GMax, GMin,
Add, Hams, and Quad volume (Table 2 and Fig. 2b), but
not TFL and GMed. No significant volume differences
were detected between legs within each group.
Discussion
This study compared bilateral isometric hip and knee
muscle strength and hip and knee muscle volume be-
tween individuals with symptomatic and radiographic
mild-to-moderate hip OA and healthy controls. Consis-
tent with our hypothesis, individuals with hip OA tended
to be weaker and have less muscle volume than those in
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Table 1 Participant characteristics of hip osteoarthritis and control groups
Characteristic Unilateral hip OA n = 12 Bilateral hip OA n = 7 Hip OA n = 19 Control n = 23
Age (years) 62.9 ± 10.0 63.0 ± 6.4 62.8 ± 8.6 58.2 ± 8.6
Males, n (%) 3 (25%) 3 (42%) 6 (32%) 8 (35%)
Height (m) 1.65 ± 0.09 1.69 ± 0.14 1.66 ± 0.10 1.69 ± 0.08
Body mass (kg) 77.3 ± 14.0 77.2 ± 15.0 77.2 ± 14.0 69.9 ± 10.0
Body mass index (kg/m2) 28.2 ± 3.5 27.1 ± 3.5 27.8 ± 3.5* 24.4 ± 3.0
Harris Hip Score (HHS)ab 69.9 ± 12.9 66.2 ± 13.5 68.6 ± 12.9 99.9 ± 0.7
Affected Contralateral Most affected Less affected (Most) affected Contralateral/Less affected Left Right
Joint space width (mm) 2.3 ± 1.1 3.5 ± 0.7 2.9 ± 0.5 3.0 ± 0.5 2.5 ± 1.0* 3.3 ± 0.7* 4.0 ± 0.5 3.9 ± 0.6
Kellgren-Lawrence grade 2, n = 4
3, n = 8
0, n = 4
1, n = 8
2, n = 4
3, n = 3
2, n = 5
3, n = 2
2, n = 8
3, n = 11
0, n = 4
1, n = 8
2, n = 5
3, n = 2
0, n = 12
1, n = 11
0, n = 18
1, n = 5
Values are mean (standard deviation) unless otherwise stated
OA osteoarthritis
*p < 0.05 hip OA compared to control group
aHHS scale – 0 = extreme hip problems and 100 = no hip problems; bMost symptomatic hip for participants with bilateral hip osteoarthritis and randomly assigned
hip for control participants; Kellgren-Lawrence grading scale – 0 = no radiographic features of hip osteoarthritis and 4 = large osteophytes
Fig. 1 Muscle and muscle group segmentation from magnetic resonance images of a representative healthy control participant; a superior view
of muscle masks segmented from an individual transverse plane slice; b-c anterior and posterior views, respectively, of 3D rendering of thigh and
hip muscles (GMIN-gluteus minimus; GMED-gluteus medius; GMAX-gluteus maximus; TFL-tensor fasciae latae; ADD-adductors;
QUAD-quadriceps; HAM-hamstrings)
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Table 2 Summary statistics for the effect of group (hip osteoarthritis versus control) on muscle strength and volume measures
Hip OA (mean ± SD) Control (mean ± SD) F, p Mean difference
(mean ± SD)




Knee flexors 0.977 ± 0.292 1.255 ± 0.281 9.579, 0.004* 0.278 ± 0.392 0.096, 0.460 0.71
Knee extensors 1.286 ± 0.344 1.664 ± 0.328 12.450, 0.001* 0.378 ± 0.462 0.164, 0.593 0.82
Hip flexors 0.898 ± 0.331 1.216 ± 0.314 9.866, 0.003* 0.319 ± 0.440 0.113, 0.524 0.73
Hip extensors 0.908 ± 0.292 1.216 ± 0.281 11.652, 0.02* 0.307 ± 0.392 0.125, 0.490 0.78
Hip abductors 0.662 ± 0.209 0.905 ± 202 14.34, 0.001* 0.244 ± 0.279 0.113, 0.374 0.87
Hip adductors 0.639 ± 0.323 0.834 ± 0.314 3.794, 0.06 0.194 ± 0.436 −0.008, 0.397 0.44
Volume (cm3/kg)
TFL 0.909 ± 0.324 0.816 ± 0.300 0.986, 0.327 0.094 ± 0.410 −0.285, 0.098 0.23
GMax 9.560 ± 2.336 11.119 ± 2.153 5.268, 0.028* 1.558 ± 2.995 0.182, 2.934 0.52
GMed 4.031 ± 0.722 4.241 ± 0.666 1.001,0.324 0.209 ± 0.911 −0.216, 0.634 0.23
GMin 1.006 ± 0.380 1.525 ± 0.352 22.048, < 0.001* 0.520 ± 0.484 0.295, 0.744 1.07
Add 10.827 ± 2.111 12.489 ± 1.947 7.380,0.01* 1.662 ± 2.668 0.420, 2.940 0.62
Hams 7.444 ± 1.548 9.117 ± 1.426 13.899, 0.001* 1.673 ± 1.957 0.762, 2.583 0.85
Quad 16.114 ± 4.512 20.769 ± 4.160 12.666, 0.001* 4.655 ± 5.701 2.001, 7.311 0.82
Add adductors, CI confidence interval, Hams hamstrings, GMax gluteus maximus, GMed gluteus medius, GMin gluteus minimus, OA osteoarthritis, Quad quadriceps,
TFL tensor fasciae latae
*Significant difference between groups (p < 0.05)
Fig. 2 Muscle (a) strengths and (b) volumes (mean ± one standard deviation) for hip OA (n = 19), and control (n = 23) groups (TFL-tensor fasciae
latae; GMax-gluteus maximus; GMed-gluteus medius; GMin-gluteus minimus; Add-adductors; Hams-hamstrings; Quad-quadriceps); Asterisk (*)
indicates significant difference between hip OA and control group
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the healthy control group. Deficts in strength were de-
tected for the hip flexors, extensors and abductors, and
the knee flexors and extensors, but not the hip adduc-
tors. Smaller muscle volumes were detected for gluteus
maximus, gluteus minimus, and the adductor, hamstring
and quadricep muscle groups, but not for tensor fascia
latae or gluteus medius. Previous research has demon-
strated generalized lower limb muscle weakness and at-
rophy in advanced stages of hip OA [26], and in the hip
abductors in earlier stages of the disease [27]. The main
and novel finding of the present study was that pervasive
deficits in lower limb muscle strength and size are also
present in mild-to-moderate stages of the disease
process. In contrast to our hypothesis, no between-limb
differences in muscle strength or volume were found in
our mild-to-moderate hip OA group. Between-limb
asymmetries in muscle strength and volume instead
appear to primarily be a feature of advanced stage hip
OA [26].
Muscle strength and volume in individuals with mild-to-
moderate hip OA
Individuals with hip OA exhibited strength deficits in
the hip and knee flexors and extensors and hip abduc-
tors relative to control participants. Hip and knee
muscle strength in the directions assessed was on aver-
age 22–26% lower than the control group. In general,
the strength deficits in the hip OA group fall within the
range reported (13–37%) in previous investigations of
hip muscle strength in hip OA [12, 39]. Only hip adduc-
tion strength was not significantly lower in the hip OA
group, but approached significance (p = 0.06) with an ef-
fect size of 0.44, which may be clinically meaningful. We
therefore interpret these findings to indicate that muscle
weakness in the most affected limb in mild-to-moderate
hip OA tends to be generalized rather than specific to
individual muscles or muscle groups and that the magni-
tude of weakness is similar between mild-to-moderate
and advanced hip OA. The underlying cause of muscle
weakness in hip OA remains unclear but could arise
from decreased physical activity and/or unloading of the
lower extremity during physical activity [34], perhaps
driven by some combination of pain and motor dysfunc-
tion. Unresolved questions that will require further in-
vestigation concern whether muscle weakness precedes
or follows the onset of hip OA, and whether weakness is
a contributing cause or consequence of hip OA.
Hip and knee muscle volumes were on average 5–30%
lower in individuals with hip OA across all muscle groups
and individual muscles assessed, with the exception of
tensor fascia latae and gluteus medius. The smaller muscle
volumes in individuals with mild-to-moderate hip OA
likely underpin their generalized deficits in hip and knee
muscle strength, and coincide with reports of advanced
hip OA [26]. In general, there was a correspondence in
the amount of weakness detected at the joint level, and
the atrophy of muscles that contributed to the measured
strength. For example, the 22–26% lower strength of the
knee flexors and extensors in the hip OA group, corre-
sponded with 18–22% reductions in muscle volume of the
hamstrings and quadriceps respectively, and suggest that
muscle atrophy in hip OA is a major mechanism of under-
lying muscle weakness in these muscles. Our findings of
lower gluteal (maximus and minimus) muscle volumes in
individuals with hip OA compared to healthy controls are
consistent with Zacharias et al. [27]. Further, our observa-
tions are broadly consistent with findings from a system-
atic review of muscle strength and size in hip OA relative
to controls [26], which suggest that advanced unilateral
hip OA is characterized by generalized muscle weakness
and atrophy of muscles in the affected limb. Although glu-
teus medius had a 5% lower volume in the hip OA group,
this mean group difference was not statistically significant.
The tensor fascia latae muscle volume was similarly not
significantly different between groups. The absence of
group differences in muscle volume for these muscles
could be explained by possible group differences in hip ab-
ductor muscle activation capacity, force sharing between
synergistic abductor muscles and muscle quality. A further
possibility is that some muscles may compensate for
reduction in strength of synergistic muscles as has been
observed in individuals with knee muscle pathology
following anterior cruciate ligament reconstruction [40].
Indeed Grimaldi et al. [20] reported larger volumes for
gluteus medius compared to healthy controls in early
stages of hip pathology compared to atrophy in later
stages.
Muscle strength and volume in the affected and less-
affected/contralateral limbs of individuals with mild-to-
moderate hip OA
Lower muscle strength and volume did not differ signifi-
cantly between-limbs in individuals with hip OA. Although
12 of 19 (63%) of our cohort had unilateral hip OA
(between-limb KL grade difference ≥1), it is possible that
the inclusion of 7 bilateral participants prevented asymmet-
ries from being detected. However, a post hoc analysis of
the unilateral hip OA sub-group did not reveal any clear
trends to support strength or volume asymmetry (data not
presented). Grimaldi et al. [20], who evaluated gluteal
muscle size in individuals with mild and advanced unilat-
eral hip OA, similarly observed no difference in muscle size
between the affected and contralateral limb in the mild hip
OA group. However, our observations contradict those of
Zacharias et al. [27], who reported lower gluteal muscle
volumes in individuals with moderate unilateral hip OA
(KL grade 2: n = 7; KL grade 3: n = 13) compared to their
contralateral side. When participants from Zacharias et al.
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[27] were dichotomized based on OA severity, only those
with KL grade = 3 demonstrated atrophy in the gluteal
muscles. Our cohort was comprised of 42% of individuals
with KL grade = 2, which in light of the findings of
Zacharias et al. [27], may suggest that muscle related asym-
metry becomes more prominent with disease progression.
A possible explanation for the lack of difference is muscle
strength between limbs in hip OA is that rather than
favouring the contralateral limb during the performance of
functional tasks, individuals with mild-to-moderate hip OA
unload both limbs through a reduction in overall physical
activity.
Reduced muscle strength and volumes in the affected
compared to contralateral limb are well documented in
individuals with end-stage hip OA [14, 16, 18, 20–22]. In
general, it is difficult to compare the findings from the
present study to those from the literature due to diffe-
rences in participant characteristics (single versus mixed
sex, pre- versus post-total hip replacement), strength
measurements (e.g. isometric versus isokinetic), and
muscles assessed. However, findings from Zacharias et
al. [27] and Grimaldi et al. [20], where a subset of lower
limb muscle strength and/or muscle volumes were mea-
sured in participants with hip OA from across the dis-
ease spectrum using a consistent approach, suggest that
asymmetries in strength and volume become more pro-
nounced with disease progression. Interventions to re-
tain bilateral muscle strength during early-middle stages
of the disease therefore appear warranted in the manage-
ment of hip OA. This recommendation is consistent
with the evidence-based clinical practice guidelines for
therapeutic exercise in the management of hip OA
which recommend land-based therapeutic exercise, most
notably strength training, to reduce pain, stiffness and
self-reported disability, and improve physical function
and range of motion [41].
Strengths and limitations
A strength of this study was that eligibility was based on
radiographic and symptomatic criteria, which minimized
the well-known risk of participant misclassification [42].
There were also several limitations to the study. First,
the study was not sufficiently powered to perform a
sub-group analysis of unilateral and bilateral participants.
A future study with a larger sample size is required to
more definitively determine whether strength and muscle
volume asymmetry is evident within these hip OA
sub-groups. More females were recruited to the hip OA
and control groups than males (hip OA: 13 female, 6 male;
control: 15 female, 8 male), which may be a source of
experimental bias. While the hip OA group in our study
had a significantly higher BMI than controls, strength and
volume measures were normalised to body mass. We
chose this method as it is common and therefore
facilitates comparison of findings with other studies that
have used the same approach and it also has physical
meaning. Strength was assessed in the present study under
isometric conditions, which may not reflect muscle func-
tion during dynamic conditions including activities of
daily living. It was not possible to segment boundaries for
some smaller muscles (e.g. internal/external hip rotators)
or muscles with insertions outside the imaged segments
(e.g. iliopsoas), and thus only large hip/knee spanning mus-
cles and muscle groups were evaluated. Further, reliability
of muscle segmentation from MRI scans was established
using data from a single participant. It is important for
future studies to more fully elucidate the implications of re-
duced muscle strength and volume in mild-to-moderate
hip OA for motor function and disease progression. Mul-
tiple statistical comparisons were made in the present
study, which has the potential to increase the risk of type 1
error. A statistical correction was not performed due of the
exploratory nature of this study [43, 44]. It is noteworthy
that the hip OA cohort from the present study also exhi-
bited reduced self-selected walking speed and altered hip
joint mechanics, including lower net hip joint loading over
a reduced range of hip motion for a longer proportion of
the gait cycle, when walking at their preferred gait speed
relative to healthy control participants [34]. These findings
are consistent with an underloading hypothesis for hip OA
progression, perhaps due in part to muscle weakness, which
could have implications for disease progression through
altered mechano-biological processes within the joint [45].
Conclusions
The main conclusion from this study is that atrophic hip
and knee muscle weakness is a distinct feature of
mild-to-moderate hip OA. These strength and muscle size
deficits tended to be generalized rather than localised to
individual muscles and/or muscle groups in the lower
limb, and have possible implications for daily function,
quality of life and OA disease progression. While no
evidence of between-limb asymmetry in muscle strength
or volume was found in the present study, intervention
early in the disease process to prevent the development of
strength asymmetries that are characteristic of advanced
hip OA appear warranted.
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